ResMed (RMD) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $230.65 +4.85%
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.58, $0.01 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $411.6 million versus the consensus estimate of $406.29 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Rothschild Redburn Starts ResMed (RMD) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
